Induced pluripotent stem cells from GMP-grade hematopoietic progenitor cells and mononuclear myeloid cells

Stem Cell Research and Therapy

Volumn 2, Issue 6, 2011, Pages

  Ohmine, Seiga ^a   Dietz, Allan B ^a   Deeds, Michael C ^a   Hartjes, Katherine A ^a   Miller, David R ^a   Thatava, Tayaramma ^a   Sakuma, Toshie ^a   Kudva, Yogish C ^a   Ikeda, Yasuhiro ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLT3 LIGAND; GUANOSINE PHOSPHATE; INTERLEUKIN 3; INTERLEUKIN 6; KRUPPEL LIKE FACTOR 4; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; STAGE SPECIFIC EMBRYO ANTIGEN 4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; HOMEODOMAIN PROTEIN; MEMBRANE ANTIGEN; NANOG PROTEIN, HUMAN; PROTEOGLYCAN; STAGE SPECIFIC EMBRYO ANTIGEN; STAGE-SPECIFIC EMBRYONIC ANTIGEN-4; TRA 1 60 ANTIGEN, HUMAN; TRA-1-60 ANTIGEN, HUMAN;

ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL EXPANSION; CELL GROWTH; COLONY FORMATION; CONTROLLED STUDY; DPPA4 GENE; ELECTRON MICROSCOPY; FEASIBILITY STUDY; GENE; GENE EXPRESSION PROFILING; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LIN28 GENE; MICROARRAY ANALYSIS; MONONUCLEAR CELL; NUCLEAR REPROGRAMMING; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PLURIPOTENT STEM CELL; PODXL GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TERT GENE; BIOLOGICAL THERAPY; CYTOLOGY; DEGENERATIVE DISEASE; GENE VECTOR; GENETICS; LENTIVIRINAE; METABOLISM; TRANSPLANTATION;

ANTIGENS, SURFACE; CELL DIFFERENTIATION; GENE EXPRESSION PROFILING; GENETIC VECTORS; HEMATOPOIETIC STEM CELLS; HOMEODOMAIN PROTEINS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; LENTIVIRUS; LEUKOCYTES, MONONUCLEAR; NEURODEGENERATIVE DISEASES; NUCLEAR REPROGRAMMING; OCTAMER TRANSCRIPTION FACTOR-3; PROTEOGLYCANS; STAGE-SPECIFIC EMBRYONIC ANTIGENS; TISSUE THERAPY;

EID: 83455186619     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt87     Document Type: Article

References (45)

1. Embryonic stem cells: are useful in clinic treatments? Aznar J, Sanchez JL, J Physiol Biochem 2011 67 141 144 10.1007/s13105-010-0064-0 21246421
2. -2011 clinicaltrials.gov: http://clinicaltrials.gov/ct2/show/NCT01345006 and http://clinicaltrials.gov/ct2/show/NCT01344993.
3. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S, Cell 2007 131 861 872 10.1016/j.cell.2007.11.019 18035408 (Pubitemid 350138099)
4. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Takahashi K, Yamanaka S, Cell 2006 126 663 676 10.1016/j.cell.2006.07.024 16904174 (Pubitemid 44233629)
5. Reprogramming of human somatic cells to pluripotency with defined factors. Park IH, Zhao R, West JA, Yabuuchi A, Huo H, Ince TA, Lerou PH, Lensch MW, Daley GQ, Nature 2008 451 141 146 10.1038/nature06534 18157115
6. Generation of human induced pluripotent stem cells from dermal fibroblasts. Lowry WE, Richter L, Yachechko R, Pyle AD, Tchieu J, Sridharan R, Clark AT, Plath K, Proc Natl Acad Sci USA 2008 105 2883 2888 10.1073/pnas.0711983105 18287077 (Pubitemid 351723638)
7. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Wernig M, Meissner A, Foreman R, Brambrink T, Ku M, Hochedlinger K, Bernstein BE, Jaenisch R, Nature 2007 448 318 324 10.1038/nature05944 17554336 (Pubitemid 47080337)
8. Induced pluripotent stem cell lines derived from human somatic cells. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA, Science 2007 318 1917 1920 10.1126/science.1151526 18029452
9. Generation of pluripotent stem cells from patients with type 1 diabetes. Maehr R, Chen S, Snitow M, Ludwig T, Yagasaki L, Goland R, Leibel RL, Melton DA, Proc Natl Acad Sci USA 2009 106 15768 15773 10.1073/pnas.0906894106 19720998
10. Generation of insulin-secreting islet-like clusters from human skin fibroblasts. Tateishi K, He J, Taranova O, Liang G, D'Alessio AC, Zhang Y, J Biol Chem 2008 283 31601 31607 10.1074/jbc.M806597200 18782754
11. Indolactam V/GLP-1-mediated differentiation of human iPS cells into glucose-responsive insulin-secreting progeny. Thatava T, Nelson TJ, Edukulla R, Sakuma T, Ohmine S, Tonne JM, Yamada S, Kudva Y, Terzic A, Ikeda Y, Gene Ther 2011 18 283 293 10.1038/gt.2010.145 21048796
12. Induced pluripotent reprogramming from promiscuous human stemness related factors. Nelson TJ, Martinez-Fernandez A, Yamada S, Mael AA, Terzic A, Ikeda Y, Clin Transl Sci 2009 2 118 126 10.1111/j.1752-8062.2009.00091.x 20161095
13. Reprogrammed mouse fibroblasts differentiate into cells of the cardiovascular and hematopoietic lineages. Schenke-Layland K, Rhodes KE, Angelis E, Butylkova Y, Heydarkhan-Hagvall S, Gekas C, Zhang R, Goldhaber JI, Mikkola HK, Plath K, Maclellan WR, Stem Cells 2008 26 1537 1546 10.1634/stemcells.2008- 0033 18450826
14. Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Nelson TJ, Martinez-Fernandez A, Yamada S, Perez-Terzic C, Ikeda Y, Terzic A, Circulation 2009 120 408 416 10.1161/CIRCULATIONAHA.109. 865154 19620500
15. iPS programmed without c-MYC yield proficient cardiogenesis for functional heart chimerism. Martinez-Fernandez A, Nelson TJ, Yamada S, Reyes S, Alekseev AE, Perez-Terzic C, Ikeda Y, Terzic A, Circ Res 2009 105 648 656 10.1161/CIRCRESAHA.109.203109 19696409
16. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Aoi T, Yae K, Nakagawa M, Ichisaka T, Okita K, Takahashi K, Chiba T, Yamanaka S, Science 2008 321 699 702 10.1126/science.1154884 18276851
17. Isolation and cultivation of human keratinocytes from skin or plucked hair for the generation of induced pluripotent stem cells. Aasen T, Belmonte JC, Nat Protoc 2010 5 371 382 10.1038/nprot.2009.241 20134422
18. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Aasen T, Raya A, Barrero MJ, Garreta E, Consiglio A, Gonzalez F, Vassena R, Bili J, Pekarik V, Tiscornia G, Edel M, Boué S, Izpisúa Belmonte JC, Nat Biotechnol 2008 26 1276 1284 10.1038/nbt.1503 18931654
19. Reprogramming of human peripheral blood cells to induced pluripotent stem cells. Staerk J, Dawlaty MM, Gao Q, Maetzel D, Hanna J, Sommer CA, Mostoslavsky G, Jaenisch R, Cell Stem Cell 2010 7 20 24 10.1016/j.stem.2010.06.002 20621045
20. Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells. Hu K, Yu J, Suknuntha K, Tian S, Montgomery K, Choi KD, Stewart R, Thomson JA, Slukvin II, Blood 2011 117 109 e119 10.1182/blood-2010-07-298331 21296996
21. Generation of induced pluripotent stem cells from human cord blood. Haase A, Olmer R, Schwanke K, Wunderlich S, Merkert S, Hess C, Zweigerdt R, Gruh I, Meyer J, Wagner S, Maier LS, Han DW, Glage S, Miller K, Fischer P, Schöler HR, Martin U, Cell Stem Cell 2009 5 434 441 10.1016/j.stem.2009.08.021 19796623
22. Effective generation of iPS cells from CD34+ cord blood cells by inhibition of p53. Takenaka C, Nishishita N, Takada N, Jakt LM, Kawamata S, Exp Hematol 2010 38 154 162 10.1016/j.exphem.2009.11.003 19922768
23. Direct generation of induced pluripotent stem cells from human nonmobilized blood. Kunisato A, Wakatsuki M, Shinba H, Ota T, Ishida I, Nagao K, Stem Cells Dev 2011 20 159 168 10.1089/scd.2010.0063 20497033
24. Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures. Chou BK, Mali P, Huang X, Ye Z, Dowey SN, Resar LM, Zou C, Zhang YA, Tong J, Cheng L, Cell Res 2011 21 518 529 10.1038/cr.2011.12 21243013
25. Successful differentiation to T cells, but unsuccessful B-cell generation, from B-cell-derived induced pluripotent stem cells. Wada H, Kojo S, Kusama C, Okamoto N, Sato Y, Ishizuka B, Seino K, Int Immunol 2011 23 65 74 10.1093/intimm/dxq458 21135032
26. Reprogramming of EBV-immortalized B-lymphocyte cell lines into induced pluripotent stem cells. Choi SM, Liu H, Chaudhari P, Kim Y, Cheng L, Feng J, Sharkis S, Ye Z, Jang YY, Blood 2011 118 1801 1805 10.1182/blood-2011-03-340620 21628406
27. Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Hanna J, Markoulaki S, Schorderet P, Carey BW, Beard C, Wernig M, Creyghton MP, Steine EJ, Cassady JP, Foreman R, Lengner CJ, Dausman JA, Jaenisch R, Cell 2008 133 250 264 10.1016/j.cell.2008.03.028 18423197 (Pubitemid 351508307)
28. Human lymphoblastoid B-cell lines reprogrammed to EBV-free induced pluripotent stem cells. Rajesh D, Dickerson SJ, Yu J, Brown ME, Thomson JA, Seay NJ, Blood 2011 118 1797 1800 10.1182/blood-2011-01-332064 21708888
29. Derivation of induced pluripotent stem cells from human peripheral blood T lymphocytes. Brown ME, Rondon E, Rajesh D, Mack A, Lewis R, Feng X, Zitur LJ, Learish RD, Nuwaysir EF, PLoS One 2010 5 11373 10.1371/journal.pone.0011373 20617191
30. Generation of induced pluripotent stem cells from human blood. Loh YH, Agarwal S, Park IH, Urbach A, Huo H, Heffner GC, Kim K, Miller JD, Ng K, Daley GQ, Blood 2009 113 5476 5479 10.1182/blood-2009-02-204800 19299331
31. Reprogramming of T cells from human peripheral blood. Loh YH, Hartung O, Li H, Guo C, Sahalie JM, Manos PD, Urbach A, Heffner GC, Grskovic M, Vigneault F, Lensch MW, Park IH, Agarwal S, Church GM, Collins JJ, Irion S, Daley GQ, Cell Stem Cell 2010 7 15 19 10.1016/j.stem.2010.06.004 20621044
32. Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. Seki T, Yuasa S, Oda M, Egashira T, Yae K, Kusumoto D, Nakata H, Tohyama S, Hashimoto H, Kodaira M, Okada Y, Seimiya H, Fusaki N, Hasegawa M, Fukuda K, Cell Stem Cell 2010 7 11 14 10.1016/j.stem.2010. 06.003 20621043
33. Cyclosporine increases human immunodeficiency virus type 1 vector transduction of primary mouse cells. Noser JA, Towers GJ, Sakuma R, Dumont JM, Collins MK, Ikeda Y, J Virol 2006 80 7769 7774 10.1128/JVI.02427-05 16840358 (Pubitemid 44092598)
34. Postentry restriction to human immunodeficiency virus-based vector transduction in human monocytes. Neil S, Martin F, Ikeda Y, Collins M, J Virol 2001 75 5448 5456 10.1128/JVI.75.12.5448-5456.2001 11356951 (Pubitemid 32488137)
35. Reprogrammed keratinocytes from elderly type 2 diabetes patients suppress senescence genes to acquire induced pluripotency. Ohmine S, Squillace KA, Hartjes KA, Deeds MC, Armstrong AS, Thatava T, Sakuma T, Terzic A, Kudva Y, Ikeda Y, submitted for publication
36. No-nonsense functions for long noncoding RNAs. Nagano T, Fraser P, Cell 2011 145 178 181 10.1016/j.cell.2011.03.014 21496640
37. Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2. Giorgetti A, Montserrat N, Aasen T, Gonzalez F, Rodríguez-Piz I, Vassena R, Raya A, Boué S, Barrero MJ, Corbella BA, Torrabadella M, Veiga A, Izpisua Belmonte JC, Cell Stem Cell 2009 5 353 357 10.1016/j.stem.2009.09.008 19796614
38. Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders. Ye Z, Zhan H, Mali P, Dowey S, Williams DM, Jang YY, Dang CV, Spivak JL, Moliterno AR, Cheng L, Blood 2009 114 5473 5480 10.1182/blood-2009-04-217406 19797525
39. Generation of germline-competent induced pluripotent stem cells. Okita K, Ichisaka T, Yamanaka S, Nature 2007 448 313 317 10.1038/nature05934 17554338 (Pubitemid 47080336)
40. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Kaji K, Norrby K, Paca A, Mileikovsky M, Mohseni P, Woltjen K, Nature 2009 458 771 775 10.1038/nature07864 19252477
41. Human induced pluripotent stem cells free of vector and transgene sequences. Yu J, Hu K, Smuga-Otto K, Tian S, Stewart R, Slukvin II, Thomson JA, Science 2009 324 797 801 10.1126/science.1172482 19325077
42. Emerging potential of transposons for gene therapy and generation of induced pluripotent stem cells. VandenDriessche T, Ivics Z, Izsvak Z, Chuah MK, Blood 2009 114 1461 1468 10.1182/blood-2009-04-210427 19471016
43. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Woltjen K, Michael IP, Mohseni P, Desai R, Mileikovsky M, Hämäläinen R, Cowling R, Wang W, Liu P, Gertsenstein M, Kaji K, Sung HK, Nagy A, Nature 2009 458 766 770 10.1038/nature07863 19252478
44. Multiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells. Subramanyam D, Lamouille S, Judson RL, Liu JY, Bucay N, Derynck R, Blelloch R, Nat Biotechnol 2011 29 443 448 10.1038/nbt.1862 21490602
45. Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Anokye-Danso F, Trivedi CM, Juhr D, Gupta M, Cui Z, Tian Y, Zhang Y, Yang W, Gruber PJ, Epstein JA, Morrisey EE, Cell Stem Cell 2011 8 376 388 10.1016/j.stem.2011.03.001 21474102